|

Translation and Validation of the French mPCOSQ (mPCOSQ-F).

RECRUITINGSponsored by CHU de Reims
Actively Recruiting
SponsorCHU de Reims
Started2025-05-12
Est. completion2027-05-12
Eligibility
Age18 Years – 45 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07016035

Summary

This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.

Eligibility

Age: 18 Years – 45 YearsSex: FEMALEHealthy volunteers accepted
Inclusion criteria:

* Women aged 18 to 45
* Fluent in french
* Having a diagnosis of PCOS according to the international recommendations published in 2023
* Willing to participate in the study
* Affiliated to the french social security system

Exclusion criteria:

* Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
* Pregnancy or breast-feeding
* Under legal protection

Conditions2

CancerPolycystic Ovary Syndrome Health-related Quality of Life

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.